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Abstract Yeast co-expressing human elongase and desaturase
genes were used to investigate whether the same desaturase gene
encodes an enzyme able to desaturate n-3 and n-6 fatty acids with
the same or different carbon chain length. The results clearly
demonstrated that a single human v5 desaturase is active on
20:3n-6 and 20:4n-3. Endogenous v6 desaturase substrates were
generated by providing to the yeast radiolabelled 20:4n-6 or
20:5n-3 which, through two sequential elongations, produced
24:4n-6 and 24:5n-3, respectively. Overall, our data suggest that
a single human v6 desaturase is active on 18:2n-6, 18:3n-3,
24:4n-6 and 24:5n-3. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
In human and other mammalian cells, microsomal v6 de-
saturation of essential fatty acids linoleic acid (18:2n-6) and
K-linolenic acid (18:3n-3) is the ¢rst and rate limiting step in
the biosynthesis of n-6 and n-3 polyunsaturated fatty acids
(PUFAs). The products of these reactions, Q-linolenic
(18:3n-6) and stearidonic acids (18:4n-3), are elongated to
dihomo-Q-linolenic acid (20:3n-6) and 20:4n-3, respectively
(Fig. 1). These fatty acids are then substrates of a v5 desatur-
ase that generates arachidonic acid (20:4n-6) and 20:5n-3
which are further elongated to 22:4n-6 and 22:5n-3 and ¢-
nally to their respective products 24:4n-6 and 24:5n-3. A sec-
ond microsomal v6 desaturation takes place on these PUFAs.
The products of this desaturation, 24:5n-6 and 24:6n-3, are
converted to 22:5n-6 and 22:6n-3, respectively, by peroxisom-
al L-oxidation [1]. In addition, two sequential elongations of
20:4n-3 (i.e. 22:4n-3 and 24:4n-3) were described by Sauer-
wald et al. as part of putative alternative steps in the synthesis
of 22:6n-3 [2]. These authors proposed that 24:4n-3 could
undergo v9 desaturation to 24:5n-3 which can act as substrate
of the v6 desaturase. Direct elongations on 18:2n-6, 18:3n-3
and 20:3n-6 are also reported.
To date, there is no conclusive evidence that the v6 desa-
turase, which recognizes 18-carbon unsaturated fatty acids
(18:2n-6 or 18:3n-3), is the same enzyme that desaturates
24-carbon substrates [3]. In this regard, Marquardt and co-
workers have cloned three human fatty acid desaturase genes
[4]. Two of these genes encode either a v5 or a v6 desaturase,
however the third gene, to which a function has not been
ascribed yet, is unlikely to represent a second human v5 or
v6 desaturase. We have recently demonstrated that, in certain
malignant human cells, the v6 desaturase impairment is not
speci¢c to any particular step of the PUFA biosynthetic path-
ways [5]. Similar results were obtained with skin ¢broblasts
from a patient with an inherited abnormality in lipid metab-
olism [6]. All these ¢ndings from di¡erent laboratories suggest
that the hypothesis of the existence of at least two distinct
enzymes still remains unsubstantiated.
Recent reports have shown that the levels of 20:4n-6,
22:4n-6, 20:5n-3 and 22:5n-3 signi¢cantly increased when a
human v5 desaturase was expressed in mouse ¢broblasts [7].
However, direct activity on both substrates of this human v5
desaturase, 20:3n-6 and 20:4n-3, has not been reported yet.
A heterologous host, Saccharomyces cerevisiae, known for
its absence of PUFA biosynthesis, was transformed with a
human fatty acid elongase and either a v6 or v5 desaturase
gene in an attempt to elucidate whether the same human
desaturase is active on n-3 and n-6 fatty acids with the same
or di¡erent chain length. We here describe the functional
analysis of these fatty acid biosynthetic enzymes using di¡er-
ent radiolabelled PUFAs.
2. Materials and methods
2.1. Chemicals
Fatty acid free bovine serum albumin (BSA), tergitol, Tris^HCl,
carbohydrates, amino acids and fatty acids were obtained from Sig-
ma-Aldrich Canada (ON, Canada). Yeast nitrogen base without ami-
no acids was purchased from Difco-Becton Dickinson (Kansas City,
MO, USA). All organic solvents (high performance liquid chromatog-
raphy (HPLC) grade) were obtained from Fisher-Scienti¢c (Fair
Lawn, NJ, USA).
[1-14C]18:3n-3, [1-14C]20:4n-6, [1-14C]20:5n-3, [1-14C]20:3n-6 and
[1-14C]18:2n-6 (99% radiochemical purity; speci¢c activity: 51^56
0014-5793 / 01 / $20.00 ß 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 3 1 3 5 - 0
*Corresponding author. 1520 Ashlee Drive, Coldbrook, NS, Canada
B4R 1A1.
E-mail address: r.deantueno@mailexcite.com (R.J. de Antueno).
1 Present address: Xenon Genetics Inc., 2386 East Mall, Vancouver,
BC, Canada V6T 1Z6.
Abbreviations: SC-Leu and SC-U-Leu, synthetic minimal medium
lacking either leucine or uracil and leucine, respectively; PUFAs,
polyunsaturated fatty acids; fatty acids are designated with a number
that refers to the number of carbons in the chain; the number after
the colon indicates the number of double bonds and the n refers to the
location of the nearest double bond from the methyl end
FEBS 25523 26-11-01
FEBS 25523 FEBS Letters 509 (2001) 77^80
WCi/Wmol) were purchased from NEN (Boston, MA, USA). [1-
14C]20:4n-3, [1-14C]24:4n-6 and [1-14C]24:5n-3 (99% radiochemical
purity; speci¢c activity: 55 WCi/Wmol) were provided by ARC (St.
Louis, MO, USA). Fatty acids were saponi¢ed with 0.1 M LiOH
and dissolved in synthetic minimal medium for yeast lacking either
leucine (SC-Leu) or uracil and leucine (SC-U-Leu), containing 1%
tergitol.
2.2. Cloning
Human v5 and v6 desaturases (GenBank accession numbers
AF226273 and AF126799, respectively) were cloned into the
pYES2/CT yeast expression vector (Invitrogen, Carlsbad, CA, USA)
for production of these desaturases as fusion proteins with a C-ter-
minal peptide containing the V-5 epitope and polyhistidine tag. The
desaturases were ampli¢ed by PCR from Chang Liver cell (America
Type Culture Collection (ATCC), Rockville, MD, USA) cDNA using
Advantage HF polymerase (Clontech, Palo Alto, CA, USA). The
cDNA was prepared by reverse transcribing RNA, isolated with
Trizol reagent (Gibco BRL, Rockville, MD, USA), using MuLV
reverse transcriptase and random hexamers. The forward primers,
5P-CACGCGAAGCTTAAAAATGGCCCCCGACCCGG-3P for v5
desaturase and 5P-CACGCGAAGCTTATGGGGAAGGGAGGG-
AAC-3P for v6 desaturase, contained the translation initiation codon
(bold-faced) as well as a HindIII site (underlined). The reverse prim-
ers, 5P-CACGCGTCTAGATTGGTGAAGATAGGCATCTAGCC-
AGAGCTG-3P for v5 desaturase and 5P-CACGCGTCTAGATTT-
GTGAAGGTAGGCGTCCAG-3P for v6 desaturase, contained an
XbaI site (underlined). PCR products were gel-puri¢ed, digested
with HindIII and XbaI, and ligated into pYES2/CT cut with the
same enzymes. The resulting plasmids encoding v5 and v6 desaturase
were designated pTh5009.1 and pTh5002.1, respectively. In these plas-
mids the desaturase is under the control of the inducible GAL1 pro-
moter.
BLASTP of the GenBank NR database with yeast ELO1 identi¢ed
a protein with unknown function (GenBank accession number
BAA91096), as a potential elongase. This protein was deduced from
cDNA (GenBank accession number AK000341) and is termed ELG3
herein. ELG3 was ampli¢ed by PCR from ZR-75-1 cell (ATCC)
cDNA, prepared as described above, using Advantage HF polymer-
ase. The forward primer, 5P-CACGCGGGATCCATCATGGAACA-
TCTAAAGGCC-3P, contained the translation initiation codon (bold-
faced) as well as a BamHI site (underlined). The reverse primer, 5P-
ATATCACGATGCGGCCGCTTATTGTGCTTTCTTGTTCATCA-
CTCC-3P, contained the translation stop codon (bold-faced) as well as
the NotI site. The PCR product was gel-puri¢ed, digested with BamHI
and NotI, and ligated into pYES2/CT cut with the same enzymes.
ELG3 was transferred from pYES2/CT into the BamHI and XbaI
sites of the pBEVY-L yeast expression vector [8]. The resulting plas-
mid was designated pLh5015.1. In this plasmid ELG3 is under the
control of the constitutive glyceraldehyde 3-phosphate dehydrogenase
promoter. (In comparison to GenBank accession number BAA91096,
the protein encoded by the ELG3 gene contains two amino acid sub-
stitutions, T31M and V179I.)
2.3. Yeast transformation
S. cerevisiae strain INVSc1 (Invitrogen) was transformed using the
lithium acetate method. Double recombinant yeast cells containing
both pTh5002.1 and pLh5015.1, or pTh5009.1 and pLh5015.1, were
grown on SC-U-Leu medium. Yeast cells transformed with pBEVY-L
alone, the cloning vector for ELG3, were grown on SC-Leu medium.
2.4. Incubation with radiolabelled fatty acids
Transformed yeast cultures (approximately 3.2U106 cells/ml;
OD600 0.4) were divided in two experimental groups. The ¢rst group
was incubated in a 125 ml Erlenmeyer £ask containing 10 ml of SC-
U-Leu medium with 2% ra⁄nose and 1% tergitol. Yeasts of the sec-
ond group were incubated in 10 ml of SC-U-Leu medium containing
1% ra⁄nose, 2% galactose (to induce the expression of the v6 or v5
desaturase which are under the control of the GAL1 promoter sup-
plied by the pYES2/CT yeast expression vector) and 1% tergitol.
Lithium salts (1 WCi) of either [1-14C]18:3n-3, [1-14C]20:4n-6,
[1-14C]20:5n-3, [1-14C]18:2n-6, [1-14C]20:3n-6, [1-14C]20:4n-3,
[1-14C]24:4n-6 or [1-14C]24:5n-3 were added to both experimental
groups at a ¢nal concentration of 25 WM. The general incubation
conditions in this study are a modi¢cation of those described in the
literature for the rat v6 desaturase expressed in yeast [9]. Brie£y, after
24 h incubation in an orbital incubator at 270 rpm and 30‡C, cells
were harvested by centrifugation at 5000Ug for 10 min at 4‡C. The
cell pellet was washed with Tris^HCl bu¡er (100 mM, pH 8.0) con-
taining 0.1% BSA. Total lipids were extracted and radiolabelled fatty
acids analyzed as described below. Triplicate incubations with each
fatty acid were performed from at least two yeast cultures.
The host yeast transformed with pBEVY-L and grown in SC-Leu
medium was used as negative control.
2.5. Lipid extraction
Cells were resuspended in 1.5 ml of water and total lipids were
saponi¢ed with 2 ml of 10% KOH in ethanol. The free fatty acids
from the saponi¢ed samples were methylated using 14% boron tri-
£uoride in methanol at 90‡C for 30 min. The resultant methyl esters
(FAME) were analyzed as described below.
2.6. Reverse phase-HPLC (RP-HPLC) analysis
Analyses of radiolabelled FAME were carried out on a Hewlett
Packard 1090, series II chromatograph equipped with a diode array
detector set at 205 nm, a radioisotope detector (model 171, Beckman,
CA, USA) with a solid scintillation cartridge (97% e⁄ciency for 14C
detection) and a reverse phase ODS (C-18) Beckman column (250
mmU4.6 mm i.d. ; 5 Wm particle size) attached to a pre-column
with a microBondapak C-18 (Beckman) insert. FAME were separated
isocratically with acetonitrile/water (95:5 v/v) at a £ow rate of 1 ml/
min and were identi¢ed by comparison with authentic standards ob-
tained from ARC and NuChekPrep (Elysian, MN, USA).
3. Results and discussion
In the presence of galactose, the cotransformed S. cerevisiae
cells, containing the human v6 desaturase and elongase
(ELG3) genes, were able to desaturate 18:2n-6 to 18:3n-6
and 18:3n-3 to 18:4n-3 (Fig. 2). These products were then
substrates of the ELG3 that elongated them to 20:3n-6 and
20:4n-3, respectively (Fig. 2B,D). The constitutively expressed
ELG3 was slightly active on 18:3n-3 as per the low levels of
20:3n-3 produced within the 24 h incubation (Fig. 2C,D).
ELG3 did not appear to elongate 18:2n-6 (Fig. 2A). This
Fig. 1. n-6 and n-3 PUFA biosynthetic pathways.
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observation might suggest the possible existence of multiple
human elongases with various substrate speci¢cities.
When the cotransformed yeast was incubated with [1-14C]-
24:4n-6 or [1-14C]24:5n-3 in the presence of galactose the
activity of the v6 desaturase was not detected, probably due
to the low uptake and thus low intracellular concentrations
of these long chain PUFAs. Indeed, under the experimental
conditions of this study, we have found that not all PUFAs
were taken up by S. cerevisiae to the same degree. Only 14%
of the total radioactivity provided as [1-14C]24:4n-6 or
[1-14C]24:5n-3 was recovered in yeast cells, whereas the re-
maining 86% of that radioactivity was detected in the medium
after a 24 h incubation. Conversely, more than 79% of
[1-14C]18:2n-6 or [1-14C]18:3n-6 and 40% of [1-14C]20:4n-6
was detected in yeast at the same incubation time (data not
shown). Therefore, radiolabelled 20:4n-6 and 20:5n-3 were
added to the culture medium in order to test the capability
of the cotransformed yeast to desaturate the 24-carbon sub-
strates as shown in Fig. 1. The ELG3 elongase was highly
active on these two PUFAs which, through two sequential
elongations, produced endogenous substrates for the desatur-
ase, 24:4n-6 and 24:5n-3 (Fig. 3A,C). Upon induction of the
v6 desaturase with galactose, the 24-carbon PUFAs were con-
verted into 24:5n-6 and 24:6n-3, respectively (Fig. 3B,D). No
activity on any of the substrates was detected in yeast trans-
formed with pYES2/CT and pBEVY-L alone (data not
shown).
These data expand the results of Cho and co-workers [10]
who were the ¢rst to clone this human v6 desaturase and test
its activity on the generally used 18-carbon PUFA substrate.
In addition, our ¢ndings in this yeast model support those from Sauerwald and co-workers [2] who have suggested that
two v6 desaturation steps active on 18:3n-3 and 18:2n-6
would compete not only with each other but also with
24:5n-3 and 24:4n-6. Sprecher, in a recent review addressing
this subject, has emphasized that the control of the v6 desa-
turase would be of considerable interest in animals or human
studies if a single enzyme is active on four di¡erent fatty acids
from both n-6 and n-3 families [1].
Further studies, this time with yeast co-expressing human
v5 desaturase and ELG3 genes, showed signi¢cant conversion
of the classical substrate, 20:3n-6 to 20:4n-6 by the desaturase
(Fig. 4). As expected, this cotransformed yeast as well as the
yeast transformed with the vectors alone (pYES2/CT and
pBEVY-L) were not capable of desaturating substrates of
the v6 desaturase (data not shown). ELG3 was able to elon-
gate 20:4n-6 sequentially to 22:4n-6 and 24:4n-6 (Fig. 4B). A
slight elongation of 20:3n-6 was only detected when the de-
saturase was not induced (Fig. 4A). Similarly, when the yeast
was incubated with 20:4n-3 without galactose, two higher
PUFA homologs were produced by the constitutively ex-
pressed ELG3 (Fig. 4C). However, 24:4n-3 was not detected
when the desaturase was induced. In such cases, 20:5n-3 was
produced from 20:4n-3 (Fig. 4D). These results con¢rm indi-
rect observations from Leonard et al. [7] performed in mouse
¢broblasts transfected with a human v5 desaturase. Addition-
ally, our results show that ELG3 is active on both 20:5n-3
and 22:5n-3.
Kinetic experiments for any of the desaturases with the
elongase in the cotransformed yeast model were not within
the scope of this study. Therefore, we were not able to deter-
mine if a competition between these enzymes for the same
substrates (e.g. 20:3n-6) could explain the lack of elongation
Fig. 2. RP-HPLC analysis of radiolabelled methyl esters of fatty
acids from yeast co-expressing human v6 desaturase and elongase,
incubated with [1-14C]18:2n-6 (A and B) or [1-14C]18:3n-3 (C and
D). Galactose was used to induce the expression of the desaturase
gene.
Fig. 3. RP-HPLC analysis of radiolabelled methyl esters of fatty
acids from yeast co-expressing human v6 desaturase and elongase,
incubated with [1-14C]20:4n-6 (A and B) or [1-14C]20:5n-3 (C and
D). Galactose was used to induce the expression of the desaturase
gene.
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of 20- and 22-carbon PUFAs upon the induction of the v5
desaturase.
Our data support the existence of putative alternative steps
of the PUFA biosynthetic routes depicted in Fig. 1. In this
regard, the presence of 22:4n-3 and 24:4n-3 has already been
shown in the plasma phospholipid fraction of infants that
received a dose of [U-13C]18:3n-3 [2]. In our experiment, the
cotransformed yeast was capable of producing 22- and 24-
carbon n-3 PUFAs from 20:4n-3 (Fig. 4). However, we could
not detect any activity of the endogenous v9 desaturase on
24:4n-3 which would have produced 24:5n-3, the substrate for
the v6 desaturase as proposed by Sauerwald et al. [2]. We
have previously con¢rmed that this yeast model has a v9
desaturase which is active on its typical substrate, 16:0, pal-
mitic acid (data not shown).
In short, our results suggest that the human v6 desaturase
gene cloned by Cho et al. [10] encodes an enzyme which is
able of generating a v6 double bond in both 18- and 24-car-
bon PUFAs and that a single v5 desaturase is capable of
introducing a v5 double bond on n-3 and n-6 20-carbon PU-
FAs. We may hypothesize that these ¢ndings can be extrapo-
lated to other mammalian desaturases based on the similar-
ities between the human, mouse and rat desaturases. Indeed,
an analysis of the amino acid sequences for the mouse and
human v6 desaturases revealed an 87% identity (96% similar-
ity) for both mammalian homologs [10]. In particular, we may
speculate that the rat v6 desaturase described by Aki et al. [9]
has a similar enzymatic capability to that ascribed to the
human gene herein. Similarly, it has recently been reported
that the 3413-bp full-length v5 desaturase cDNA cloned from
rat liver contains an open reading frame of 447 amino acid
residues sharing 92% similarity with its human counterpart
[11]. Further investigations are needed to con¢rm this hypoth-
esis and to determine the substrate speci¢city of these en-
zymes. Such experiments may require the cloning, isolation
and puri¢cation of these enzymes from di¡erent mammals
in an attempt to reconstitute them in arti¢cial membranes
and perform kinetic analyses with n-3 and n-6 PUFAs. Over-
all, our ¢ndings will contribute to the understanding of the
biochemical and physiological roles of fatty acid desaturases
in normal tissues and to the design of strategies for the mod-
ulation of their activities in disease.
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